(Q43979783)

28 November 2017

title

Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil (English)

1 reference

28 November 2017

0 references

1 reference

1 reference

4

1 reference

28 November 2017

Dauvilliers Y

1

1 reference

28 November 2017

Neidhart E

series ordinal

2

1 reference

28 November 2017

Billiard M

series ordinal

3

1 reference

28 November 2017

publication date

1 January 2002

1 reference

The Pharmacogenomics Journal

28 November 2017

published in

1 reference

28 November 2017

volume

2

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

65-68

1 reference

Pharmacological aspects of human and canine narcolepsy

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

MAO-A and COMT polymorphisms and gene effects in narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

Pharmacogenetics and psychopharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

7 January 2021

Hypothalamic arousal regions are activated during modafinil-induced wakefulness.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

7 January 2021

Modafinil binds to the dopamine uptake carrier site with low affinity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

7 January 2021

Dopaminergic role in stimulant-induced wakefulness.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

7 January 2021

Determination of the D- and L-enantiomers of modafinil in human plasma utilizing liquid-liquid extraction and high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500088

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500088

1 reference

28 November 2017

1 reference